Aerosol generation and characterization of multi-walled carbon nanotubes exposed to cells cultured at the air-liquid interface by William W. Polk et al.
REVIEW Open Access
Aerosol generation and characterization of
multi-walled carbon nanotubes exposed to
cells cultured at the air-liquid interface
William W. Polk1, Monita Sharma2, Christie M. Sayes3, Jon A. Hotchkiss4 and Amy J. Clippinger5*
Abstract
Aerosol generation and characterization are critical components in the assessment of the inhalation hazards of
engineered nanomaterials (NMs). An extensive review was conducted on aerosol generation and exposure
apparatus as part of an international expert workshop convened to discuss the design of an in vitro testing strategy
to assess pulmonary toxicity following exposure to aerosolized particles. More specifically, this workshop focused on
the design of an in vitro method to predict the development of pulmonary fibrosis in humans following exposure
to multi-walled carbon nanotubes (MWCNTs). Aerosol generators, for dry or liquid particle suspension aerosolization,
and exposure chambers, including both commercially available systems and those developed by independent
researchers, were evaluated. Additionally, characterization methods that can be used and the time points at which
characterization can be conducted in order to interpret in vitro exposure results were assessed. Summarized below
is the information presented and discussed regarding the relevance of various aerosol generation and
characterization techniques specific to aerosolized MWCNTs exposed to cells cultured at the air-liquid interface (ALI).
The generation of MWCNT aerosols relevant to human exposures and their characterization throughout exposure in
an ALI system is critical for extrapolation of in vitro results to toxicological outcomes in humans.
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Background
Multi-walled carbon nanotubes (MWCNTs) are used
in a number of consumer products, increasing the po-
tential for inhalation exposure of these materials.
Studies suggest that MWCNTs may pose a respiratory
hazard to humans (e.g., the development of pulmon-
ary fibrosis), depending on their physico-chemical
characteristics [1–7]. Because of the possible link
between inhalation exposure of MWCNTs and re-
spiratory toxicity [8], there is interest in better under-
standing the mechanisms by which MWCNTs can
induce inhalation toxicity. Regulatory agencies, such
as the U.S. Environmental Protection Agency (EPA)
Office of Pollution Prevention and Toxics (OPPT),
recommend a 90-day rat inhalation test for MWCNTs
if they present or may present an unreasonable risk
to human health or the environment (as defined
under Section 5 of TSCA) and are projected to be
commercially produced.
Due to the substantive time, cost, and animal numbers
required to conduct traditional in vivo inhalation toxicity
tests there is much interest in in vitro methods to assess
the toxicity of these materials. In vitro models have
shown promise as human-relevant alternatives to animal
testing, and have the capability to rapidly screen the vast
number of substances that need to be assessed for tox-
icity. In vitro tests range from simple acellular or cellular
high throughput tests to more complex tests, including
three-dimensional (3-D) co-culture systems that better
recapitulate the biology, physiology, and exposure dy-
namics that occur in human airways. An example of a
simpler in vitro model for testing the lung effects of
NMs could be submerged cultures of a single cell type,
and an example of a more complex system could be a
co-culture system of relevant cell types exposed to
aerosolized NMs at the air-liquid interface (ALI). The
two test types are complementary to one another in
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capability and relevance, offering high throughput (sub-
merged cultures) and the potential for simulating rele-
vant dosimetry with enhanced extrapolatability to the in
vivo condition (3-D ALI cultures) when combined in a
tiered testing strategy.
Inhalation toxicity was the subject of an international
workshop held in Washington, D.C., USA on February
24–25, 2015. The workshop focused on the development
of an in vitro test to predict the development of pulmon-
ary fibrosis in cells exposed to aerosolized MWCNTs
(Clippinger et al., this journal issue). Based on a litera-
ture review and workshop discussions, an in vitro system
to assess pulmonary fibrosis following MWCNT expos-
ure should consider aspects such as the mode of expos-
ure (e.g., aerosol exposure of ALI cultures versus liquid
media exposure of submerged cultures), relevant recep-
tor (e.g., choice of cell types), concentration, and dur-
ation of exposure (e.g., relevance to real exposure
scenarios). Characterization at multiple points through-
out the MWCNT lifecycle is also important to under-
stand the human relevance of the NM form present in
the in vitro system. Presented below are the consider-
ations related to conducting in vitro toxicological studies
of aerosolized MWCNTs, including the apparatus and
characterizations relevant to the development of an in
vitro model to predict pulmonary fibrosis by monitoring
pro-fibrotic signals in cells cultured at the ALI following
exposure to MWCNTs.
Nanomaterial targets in the airways
When aerosolized, NMs can exhibit particle characteris-
tics (e.g., size, density, and orientation) that determine
their distribution and penetration into different areas of
the respiratory system. The respiratory system can be di-
vided into three main regions — nasopharyngeal, tracheo-
bronchial, and alveolar — and is composed of more than
40 types of specialized cells. The alveoli are in a privileged
location only accessible by particles with small aero-
dynamic diameter (usually ranging in size from 0.01–
1 μm), are the primary site of gas exchange, and exhibit
unique physiology not recapitulated in other parts of the
airway [9]. The nasopharyngeal and tracheobronchial re-
gions that constitute the conducting airways are covered
by an extracellular fluid layer containing secreted high
molecular weight glycoproteins (mucins) and watery se-
cretions, which facilitate the removal of deposited particles
(>10 μm) via the mucociliary escalator, active immunocyte
surveillance, recruitment, and phagocytosis. Unlike the
conducting airways, the alveoli only have a very thin (10–
20 nm) epiphase consisting principally of surfactant,
serum, and secreted proteins and lack mucociliary clear-
ance allowing for longer retention of particles that reach
the alveoli [10–12]. Additionally, the conducting airways
limit systemic translocation of particles due to their thick
epithelial barriers with deep, torsional channels, ability to
slough damaged surface epithelial cells without loss of
barrier integrity, and separation of blood from the airway
by smooth muscle and connective tissue. Comparatively,
alveoli are a very thin tissue barrier (~21 μm), exhibiting
the shortest distance in the body between blood and the
atmosphere [9, 13–17].
While significant advancements have been made to
understand the role of alveoli in disease processes and
outcome, much remains unknown because of the inher-
ent limitations of the current test models. Therefore,
there has been significant investment in the develop-
ment of in vitro lung models that include relevant cell
types cultured and exposed under physiologically rele-
vant conditions. For instance, it has been suggested that
the exposure of alveolar cells cultured at the ALI, in
conjunction with other relevant cell types (such as mac-
rophages and fibroblasts), is an ideal model to evaluate
the inhalation toxicity of NMs [18]. Additionally, in
order for such a model to accurately reflect human-
relevant in vivo exposure, the mode of administration of
NMs should be carefully considered. Thus, it is critical
to evaluate the suitability of available cell culture systems
for studying NMs as well as the techniques for aerosoliz-
ing and exposing NMs to cells cultured at the ALI.
Exposure methods
Cell cultures can be exposed to aerosolized materials by
direct and indirect methods. Indirect exposure methods
for aerosol studies typically involve collection of aerosols
on sampling substrates (e.g., filter) or collection appar-
atus (e.g., wetted wall cyclones, wetted rotating vane im-
pactors, or liquid impingers), followed by recovery of the
collected aerosols and suspension of solid aerosols in
culture medium before exposure of cells in a submerged
culture [19, 20]. This indirect exposure technique has
been used to investigate biological effects of a wide
range of test materials from NMs to near-road ambient
particles [21–23]. Although such techniques offer advan-
tages for the testing of aerosols collected on-site, the
intermediate steps, such as extraction of collected aero-
sols from the sample collection matrix and solubilization
in exposure medium, could potentially alter the aerosol
form and lead to false assessments.
Direct exposure methods are used for gas-phase ex-
posure of test aerosols using several exposure tech-
niques. Direct exposure methods enable administration
of aerosolized materials directly to cultured cells under
submerged conditions, intermittent exposure by a rocker
platform, or continuous exposure at the ALI, among
others [20, 24]. Direct continuous exposure at the ALI is
more representative of human-relevant exposures than
intermittent exposure and submerged systems, and it
can be used to assess the potential hazards associated
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with aerosolized materials in a scalable, flexible,
dosimetrically-relevant format that addresses the chal-
lenges put forth for modernizing toxicology testing [25].
In an ALI system, target cells are cultured on perme-
able and porous cell culture inserts (e.g., Transwell® in-
serts) and exposed to test atmospheres continuously on
the apical surface, simulating the contact of pulmonary
cells with inhaled air, while being nourished with
medium from the basolateral surface. The ALI system
provides a larger interface between airborne components
and target cells as compared to the intermittent expos-
ure or submerged exposure conditions. Additionally,
ALI systems can limit the transformation of NM proper-
ties due to their interaction with the medium because
the depth of the liquid on the surface of the ALI cell
layer is significantly lower in comparison to submerged
cultures. This is important because the transformations
that NMs undergo in the exposure medium may influ-
ence the accuracy and reproducibility of the exposure.
For example, one study showed aerosolized particles ex-
posed at the ALI of a 3-D lung cell model to undergo far
less agglomeration and thus less sedimentation com-
pared to submerged cultures [26].
Development of ALI systems that recapitulate the hu-
man lung is ideal for testing MWCNTs, or other sub-
stances that may be inhaled, for their potential to cause
fibrosis. While less complex systems, such as submerged
cell cultures, are useful in understanding toxicity, ALI
exposure of primary human cells cultured in a physiolo-
gically relevant 3-D configuration can aid in human risk
assessment. Exposure of cells to aerosolized substances
at the ALI requires an aerosol generator (to generate the
test MWCNT atmosphere) and an exposure chamber (to
deliver the aerosolized test MWCNT atmosphere to the
cells at ALI). Figure 1 shows the basic configuration for
an ALI exposure system. The aerosol generators and ex-
posure chambers that are available to use with
MWCNTs are discussed in the following sections.
Aerosol generation of MWCNTs
There are several methods commonly used for aerosol
generation that differ in the basic principle used to gen-
erate the aerosols. Oberdörster et al. provides a compre-
hensive review of the generator and exposure systems
that may be adapted to in vitro systems [27]. The phys-
ical characteristics of the material to be aerosolized, such
as density, viscosity, state of matter, and target aerosol
size, determine which generator should be used.
MWCNTs can be delivered to cells either as a dry solid
(dust) or liquid particle suspension aerosol. For liquid or
biological materials, collision nebulizers, jet nebulizers,
ultra-sonic atomization, or vibrating membrane genera-
tors are often used; whereas, the generation of
aerosolized solid materials have typically employed the
use of spray-drying, rotating scrapers, venturi-style
powder dispersions, or fluidized powder bed methods
[28–31]. When MWCNTs are delivered in a suspension
(for instance, when using a nebulizer), it is important to
understand if the suspension or carrier solvent contrib-
utes to the observed biological effect. Use of a dry aero-
sol generator (e.g., acoustic) allows for the evaluation of
the relevance of the deposited form and concentration
to the realistic exposure. When using nebulization,
MWCNTs can be suspended in simulant lung surfactant;
for dry aerosol generation methods, a cell line that se-
cretes lung surfactant can be used to further simulate
physiological conditions.
Descriptions of commonly used aerosol generation
methods are shown in Table 1 as well as the type, size,
concentration, and duration of aerosol generated using
each. Each of the techniques has strengths and weak-
nesses depending on the nature of the material to be
aerosolized, the particle size and concentration needed,
and the duration of exposure. For instance, to assess the
risk to humans, the ideal aerosol generator would be
capable of generating MWCNTs in the human respirable
size range (that is, particles that enter the lower respira-
tory tract and have a mass median aerodynamic diam-
eter (MMAD) of between 1 and 3 microns) [32, 33].
Therefore, an aerosol generator should be carefully se-
lected based on its suitability with the chosen MWCNT
type and the requirements of the study design.
Exposure chambers for MWCNT aerosolization
Chambers that can be used to expose cells cultured at
the ALI to aerosolized materials have been described in
the literature and include both commercially available
systems and those developed by independent researchers
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Fig. 1 Basic configuration of a system for exposing cells to aerosolized
substances at the ALI. Such a system requires an aerosol generator and
an exposure chamber. Clean air controls may be incorporated as well
as a means to quantify the cellular dose (e.g., using a quartz crystal
microbalance (QCM) and/or electron microscopy (EM) grids) to relate
the outcomes to human-relevant exposures
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factors, such as cost, ease of availability and use, level of
throughput, exposure time duration, and the number of
examples of use in the published literature. Based on
these factors, chambers from three organizations —
VITROCELL® Systems, Cultex® Laboratories GmbH, and
the University of Bern — were selected as most relevant
for testing MWCNTs (Table 2). The chambers from
VITROCELL® and Cultex® are commercially available,
while the chamber from the University of Bern is pro-
duced in bulk (five at a time) by an independent re-
searcher and is available on demand.
VITROCELL® Systems offer multiple chambers, includ-
ing the ‘original’ (VITROCELL® 6, 12, and 24) and the
Cloud (VITROCELL® Cloud 6, 12, and 24) set-ups. Cultex®
Laboratories offer two chambers: the Radial Flow System
(RFS) and the RFS Compact. The University of Bern man-
ufactures an exposure module called the Nano Aerosol
Chamber for In-Vitro Toxicity (NACIVT). Importantly,
organizations frequently update existing modules or add
new modules to their product line, and the information
below is based on the status at the time of this publication.
The chambers reviewed have several common fea-
tures, including their compatibility with commercially
available cell culture inserts and multiple aerosol
generators, a mechanism to regulate temperature dur-
ing exposure, and the ability to expose cells to
aerosolized MWCNTs. However, there are differences
that make each system unique, and these differences
are detailed in the following sections.
Basic chamber configuration
Testing for the purpose of hazard assessment or identifi-
cation requires specific attention to the number of repli-
cates, appropriate controls, and quality assessment of the
experiment. As the available aerosol exposure chambers
exhibit limited end-user flexibility to modify the system
configuration, the general need of the experiment must be
assessed before deciding which system to use. For ex-
ample, consideration should be given to whether the ex-
posure chamber is: (1) capable of consistently delivering
and depositing MWCNTaerosols at multiple dilutions; (2)
compatible with different types of aerosol generators; (3)
capable of determining the deposited dose; (4) readily
cleaned; and (5) regularly available and consistently repro-
duced to facilitate interlaboratory transferability. Further-
more, the size of the cell culture inserts, the number of
wells, and the number of different exposure concentra-
tions that could simultaneously be tested per exposure
system should be considered. To understand mechanisms
of complex pathological outcomes, it is critical to focus on
specific inter- and intra-cellular biomarkers (e.g., monitor
multiple pro-fibrotic markers to understand the develop-
ment of fibrosis), which will require a larger number of
cells per exposure than are normally cultured in high
throughput wells. Similarly, establishing a dose-response
requires testing multiple concentrations of the test sub-
stance in one experiment, and therefore, it would be ideal
to have a chamber with separate modules to accommo-
date different exposure concentrations (doses).
Table 1 Aerosol generators





Nebulizer Droplets are formed with an atomizer
or in a fountain formed by ultrasonic













High voltage is applied to a metal capillary
end containing flowing liquid. Expelled
charged droplets fragment when
electrostatic forces exceed surface





2- 100 nm Optimal
for 4 h
5 ng/cm2/min for in vitro




Small beads are fluidized by air, and the
turbulent motion and bead interaction
disperses powder added to the bed.
Solid 20–500 μm Greater
than 3 h
0.5–40 mg/m3 [31], [36]
Acoustic Includes an acoustic energy source and a
diaphragm(s) that produce a pressure
gradient.





15 mg/m3 or more [37]
Brush feed Composed of a screw feeder, rotating brush,
and a cyclone designed to remove larger
particles to aerosolize carbon fibers.






Dust feeder The surface of a cake of compacted powder
is scraped at a controlled rate, by mechanical
scraping and blown by compressed air.
Solid Same as the
original
particle size
>20 h Concentration of the output
aerosol can be controlled by
adjusting the air-flow rate
[27, 39],
[40]
The table provides a brief description of aerosol generators that are applicable to MWCNTs, including the principle of aerosol generation, the type of material that
can be aerosolized, the size and concentration of the aerosolized particle, and the duration of exposure to the aerosolized particles
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Table 2 Characteristics of air-liquid interface exposure chambers for in vitro cell cultures





VITROCELL® 6/6 VITROCELL® Cloud 6 Cultex® RFS NACIVT
• 6-well inserts (can use adaptors
to adapt to 12 or 24-well-sized)
• 6-well inserts • 6, 12, or 24-well inserts • 6-well inserts
• compartments for exposing 6
cell culture inserts
• compartments for exposing 6
cell culture inserts: 6 inserts at
one exposure; no clean air
control
• compartments for exposing 3
cell culture inserts - all exposed






• allows for separate clean air
exposure in one module:
• 1 well can be used for the
(optional) microbalance.
• would have to purchase 2
modules for clean air control
• would have to
purchase 2 modules
for clean air control
o 3 replicates clean air control
o 3 replicates of one dose (or 2
replicates plus optional 1 well
for microbalance)
VITROCELL® 12/12 VITROCELL® Cloud 12 Cultex® RFS Compact
• 12-well inserts (can use adaptors
to adapt to 24-well-sized)
• 12-well inserts • 12 or 24-well inserts
• compartments for exposing 12
cell culture inserts
• compartments for exposing
12 cell culture inserts
• compartments for exposing 6
cell culture inserts
• allows for separate clean air
exposure in one module:
• allows for separate clean air
exposure in one module:
• allows for separate clean air
exposure in one module
o 3 replicates clean air control o 3 replicates for clean air control
o 3 dose dilutions with 3 replicates
per dilution (or 2 replicates plus
optional 1 well for microbalance)
o 9 inserts at one exposure
(1 well can be used for the
optional microbalance)
VITROCELL® 24/24 VITROCELL® Cloud 24
• 24-well inserts • 24-well inserts
• compartments for exposing 24
cell culture inserts
• compartments for exposing
24 cell culture inserts; 24 inserts
at one exposure (1 well can be
used for the optional
microbalance)
• allows for separate clean air
exposure in one module:
• would have to purchase 2
modules for clean air control
o 4 replicates clean air control
o 5 dose dilutions with 4 replicates
per dilution (or 3 replicates plus
optional 1 well for microbalance)
Commercially
available?
Yes Yes Yes No
Deposited-dose
determination
• The microbalance is capable
of measuring the deposition in
the module at a resolution of
10 ng/cm2.
1 well can be used for the
microbalance (optional).
Gravimetric methods,
using the precision balance.
One of the wells is






• For the 6/6 and 12/12, a
built-in microbalance option
is available. A microbalance
sensor would occupy one
compartment; therefore, the
module should have at least 4
compartments in order to allow
3 replicates for exposure.
• For the 24/24, the purchase of a
separate, standalone 12/1 CF
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The ability to run a clean air exposure simultaneously
with the MWCNT is ideal to associate the changes in bio-
logical responses to the test material. Some of the chambers
(including VITROCELL® 6/6, 12/12, 24/24, Cloud 12, and
Cultex® RFS Compact) provide the option of running clean
air control experiments at the same time as the test mater-
ial. For the chambers not capable of running simultaneous
clean air control experiments (including VITROCELL®
Cloud 6 and 24 Cultex® RFS, and NACIVT), either separate
modules need to be purchased (one for the clean air control
and one for the test substance), or if only one module is
available, the clean air control experiment and test material
experiment have to be run separately. This will double the
time needed to conduct the study and will require that the
module and auxiliary equipment are thoroughly cleaned be-
tween experiments to remove all traces of MWCNTs.
Overall, the focus and goal of the study should be consid-
ered when choosing the exposure chamber. Although this
review focuses on the three chambers (VITROCELL®, Cul-
tex®, and NACIVT), the parameters described would also
be relevant for the evaluation of other chambers.
Modularity
The exposure systems from the three manufacturers differ
in their flexibility of peripherals and connections, with
VITROCELL® Systems (with the exception of the VITRO-
CELL® Cloud) being more modular in comparison to the
Cultex® and NACIVT systems. Although modularity can
provide the ability to fine tune the system and to expose
different materials or different exposure concentrations
(doses) at the same time, these modifications should only
be made by someone with appropriate expertise and train-
ing since small variations in parameters (such as length of
peripheral tubing) can impact the particle size and con-
centration of the MWCNT exposure atmosphere. The
Cultex®, NACIVT, and the VITROCELL® Cloud systems,
on the other hand, are built as one unit.
NM deposition
While all of the systems described above (except the
VITROCELL® Cloud systems) allow for the use of different
types of aerosol generators, there are considerable differ-
ences between the systems with regards to the duration for
which the cells can be exposed to the aerosolized NMs (see
Table 2). Exposure duration can significantly affect the
amount of MWCNTs generated and deposited onto the cell
layer and should therefore be carefully chosen. Large or
dense particles in a moving airstream can be readily depos-
ited through settling or impaction, as inertial and gravimet-
ric forces are great enough to overcome thermodynamic
and flow forces that would keep the particles suspended.
Conversely, low-density particles, like MWCNTs, and those
smaller than 100 nm deposit primarily via diffusion [42].
The issue of low deposition can be overcome by electro-
static deposition enhancement, which is a technique that
uses charge to increase the efficiency of deposition by sev-
eral fold (5–10 fold). For some materials, charge must first
be added to the particles; however, this step is not necessary
for aerosolized MWCNTs, which are extremely charged.
The VITROCELL®, Cultex®, and NACIVT are adaptable to
electrostatic deposition but dose enhancement is not avail-
able for VITROCELL® Cloud because it uses liquid aerosoli-
zation (i.e., nebulization) of MWCNTs, which yields high
deposition efficiency. Although the physiological relevance
of using electrostatic deposition is debatable, specified and
reproducible concentrations of MWCNTs can be adminis-
tered to cells via electrostatic deposition of aerosolized ma-
terials or nebulization of MWCNTs dispersed in a relevant
medium (e.g., simulant lung surfactant).
Monitoring the deposited dose
The exposure chambers described above come with the
option of a quartz crystal microbalance (QCM) that al-
lows for a relatively quick and easy way to gauge depos-
ition at a resolution of 10 ng/cm2. NACIVT also has the
Table 2 Characteristics of air-liquid interface exposure chambers for in vitro cell cultures (Continued)




The VITROCELL® 6/6 is compatible
with electrostatic deposition.
Not compatible with electrostatic
deposition, but due to high
deposition efficiency of NMs in the
Cloud, electrostatic deposition is
not needed (Cloud is equipped
with a nebulizer that generates
liquid aerosols).
Compatible with electrostatic




The 12/12 and 24/24 are not,
but in those cases, the
VITROCELL® 6/6 modules can
be used with adaptors for
12 or 24-well inserts.
Exposure time
duration





May be used with a wide
range of aerosol generators.
Compatible only with the aerosol
generator, which is part of the
delivery (vibrating mesh type
for liquid aerosols).
May be used with a wide
range of aerosol generators;
One option is the Cultex® dust
generator, which is a Mitchell
or screw mill type.
May be used with a
wide range of aerosol
generators; Can be
placed close to the
workplace or
aside a busy street.
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option of an internal aerosol electrometer to measure
particle concentration in real time, so that the particle
dose administered to the cells can be estimated. Alterna-
tive analytical methods to determine the deposited dose
of MWCNTs for ALI cell cultures that can be used with
all the available chamber systems involve techniques,
such as laser spectrometry and electron microscopy
(scanning electron microscopy (SEM) and transmission
electron microscopy (TEM)) [43, 44].
Characterization of MWCNTs for assessing pulmonary
toxicity using ALI systems
In addition to choosing the appropriate aerosol gener-
ation and exposure apparatus, it is critical to
characterize MWCNTs to associate the observed end-
point to the causative NM property. Aerosol generation
and exposure systems can be equipped with auxiliary
equipment to characterize MWCNTs at various time
points. There is consensus among researchers that
characterization of the administered dose (used here to
describe the exposure concentration times the volume of
test atmosphere that flows through the ALI chamber)
alone is not sufficient as NM properties may change fol-
lowing deposition and cellular uptake. It is therefore im-
portant to characterize and understand the MWCNT
form throughout its lifecycle.
Ideally, physico-chemical properties of MWCNTs
would be characterized in five separate stages (Fig. 2).
The first stage occurs prior to aerosolization (pristine
form/as supplied), the second is the MWCNT atmos-
phere present within the exposure chamber (adminis-
tered dose), the third stage is the MWCNTs that settle
on the cell surface (deposited dose), and the fourth stage
is the MWCNTs taken up by the cells (cellular dose). In
addition to the aforementioned stages, the fifth stage in-
volves post-exposure evaluation of MWCNT transfor-
mations during the course of the assay, such as after
each time point. The MWCNT characteristics that are
relevant to some of the aforementioned stages include,
but are not limited to: 1) agglomerate structure and (de)
agglomeration potential; 2) impurity profile/content; 3)
effective density (specific gravity) of the deposited form
Fig. 2 The schematic shows the stages that are most critical for NM characterization and the techniques relevant to MWCNTs. Stage 1 involves
characterization of the NM in its pristine form; stage 2 involves characterization of the administered dose; stage 3 is characterization of the
deposited dose; stage 4 is characterization of the cellular dose; and stage 5 involves post-exposure evaluation of NM transformations during the
course of the assay. Each stage looks at particular NM properties and requires specific techniques. The techniques mentioned in the schematic
are Brunauer, Emmett and Teller (BET), scanning electron microscopy (SEM), transmission electron microscopy (TEM), inductively coupled
plasma-mass spectroscopy (ICP-MS), differential mobility analyzer (DMA), scanning mobility particle sizer spectrometers (SMPS), aerodynamic
particle sizer (APS), micro-orifice uniform deposit impactor (MOUDI), and organic carbon/ elemental carbon (OC/EC) mass spectroscopy
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of the NM; 4) bivariate length and diameter distribution
(BVD); 5) surface charge; 6) surface area; 7) rigidity; 8)
dustiness; and 9) cellular uptake. While evaluating the
MWCNTs at every stage is ideal, it is very resource inten-
sive. Therefore, a list of characteristics should be priori-
tized to identify the properties of the MWCNTs that are
critical to understand the context-specific fate of NMs
and their subsequent biological effects. These properties
and relevant characterization techniques have been
depicted in Fig. 2 and described in the following sections.
Stage1: characterization of MWCNTs as supplied
MWCNTs have diverse physico-chemical properties that
are dependent on the procedures used to synthesize
them and are relevant to their prospective use. Depend-
ing on the synthesis process, MWCNTs can be produced
in varying sizes (length and diameter), shapes (straight,
rigid, bent, curled, and flexible), and with varying surface
chemistry (oxidation status, functionalization, and trace
metal content). The diverse physico-chemical properties
dictate the lifecycle transformations (e.g., agglomeration,
oxidation, and degradation) that MWCNTs will undergo,
which eventually translate to different biological and
ecological impacts of these MWCNTs.
A number of techniques are available to characterize
the pristine form of MWCNTs and have been described
in the reports published by the European Commission
Joint Research Center (JRC) and the United States Na-
tional Institute for Occupational Safety and Health
(NIOSH) [8, 45]. Table 3 indicates the properties charac-
terized for the pristine form of MWCNTs from various
manufacturers and the techniques used, as described in
the published literature. Physical dimensions, including
length and diameter to estimate aspect ratio, are usually
determined using electron microscopy based techniques
(SEM and TEM). Specific surface area can be deter-
mined using the Brunauer, Emmett and Teller (BET)
method; x-ray diffraction can be used to detect the crys-
tal structure; EDS coupled with SEM or TEM can be
used to detect the composition of MWCNTs and pres-
ence of catalysts; and RAMAN spectroscopy can be used
to analyze oxidation status and defects.
Stage 2: administered dose
The administered dose is the MWCNT aerosol atmos-
phere produced within the exposure chamber at a spe-
cific concentration to be tested in the in vitro system. It
is analogous to the inhaled dose in an in vivo inhalation
exposure study in that it reflects the concentration of
the test material and represents the maximal potential
dose if all of the test material were deposited. It is im-
portant to characterize the administered dose to deter-
mine the the physico-chemical composition and form of
the test material that is ultimately deposited on cells at
the ALI. Chemical properties of the aerosol (e.g., com-
position, redox potential, and impurities/defects) and the
physical features (e.g., particle and mass concentration,
settling rates, aerodynamic particle size distribution, and
the agglomeration of particles) should be characterized.
Physical features of aerosolized MWCNTs may be
measured using a scanning mobility particle spectrom-
eter (SMPS) which includes a differential mobility
analyzer (DMA) to determine particle size distribution
and a condensation particle counter (CPC) to measure
the particle count concentration. An aerodynamic par-
ticle sizer (APS) may be used alone or in conjunction
with an SMPS to determine aerodynamic properties of
the test material. Additionally, a micro-orifice uniform
deposit impactor (MOUDI) is used for precise, high ac-
curacy aerosol sampling and for collecting size-
fractionated particle samples for gravimetric and/or
chemical analysis. The techniques should be chosen
based on the NM type; for instance, SMPS might not be
appropriate to characterize charged MWCNTs [56]. In
addition to aerosol characterization, determination of
parameters, such as pressure, temperature, air flow, and
relative humidity, inside the exposure-chamber is critical
since these parameters can affect the aerosol form that
reaches the apical surface of the cells at the ALI.
Stage 3: deposited dose
The deposited dose is the total amount of MWCNTs that
deposit on the apical cell layer and is different from the
administered dose. Determination of the dose-response
relationship requires an accurate measurement of the de-
posited particle mass onto the cell culture. The most com-
mon way to determine the deposited dose is to use the
sensor of a QCM [57–59]. The QCM is placed in one
empty well of the exposure chamber and exposed to the
aerosol. The deposited mass per unit area is monitored as
a function of exposure time that is used in calculating the
particle concentration. In addition to determining the
mass of the deposited MWCNTs, it may be critical to ex-
press dose based on the number of particles deposited, as
fibers, such as asbestos, are measured in terms of the
number of particles per unit volume. The number of fibers
deposited can be determined using electron microscopy
based methods, where a TEM or SEM grid is placed in the
well, and the particles can be counted using representative
images of the deposited test material to estimate total par-
ticle count. In addition to particle mass and number, sur-
face area is another metric that is considered at the
Organisation for Economic Co-operation and Develop-
ment (OECD) level [60].
Stage 4: cellular dose
The fourth stage of characterization is determining the
form and concentration of internalized cellular dose of
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Table 3 Examples of MWCNTs with their characterization information taken from the published literature
MWCNTs type/manufacturer Characterization Ref.
MWNT-7 (lot #05072001 K28)/Mitsui & Co., Inc. (USA) MWCNT [5, 46–50]
L (SEM, μm) 3.86
D (SEM, nm) 49 ± 13.4
Trace metal contamination [sodium (0.41 %)
and iron (0.32 %)] (Also reported 1.32 % for
total and 1.06 % for iron content)
0.78
SSA (BET, m2/g) 26
Zeta potential (mV) -11
Number of walls 20–50
Baytubes/Bayer Material Science, (Germany; no longer
commercially available)
MWCNT [1, 50]
Cobalt content (%, wt/wt) (ICP-OES) 0.46
Content of cobalt (Co) (%, wt/wt) (AAS) 0.53
Elemental analysis (% carbon-oxygen) 98.6–1.4
SSA (BET, m2/g) 253
Bulk density (g/cm3) 0.16
NM400 and NM402/JRC NM400 [45, 51, 52]
L (SEM, μm) 0.7–3
D (SEM, nm) 5–35
Impurities total, % Al, % Co 5.38 total,
0.24, 0.58
(Also reported 13 % for total impurities)
Defects 1.2
SSA (BET, m2/g) 245.8
NM401/JRC CNTLarge [45, 52]
L (SEM, TEM, μm) 4.05 ± 2.4
D (SEM, TEM, nm) 67 ± 26.2
Impurity (%) 3
SSA (BET, m2/g) 14.6
NM402/JRC NM402 [45, 51]
L (SEM, μm) 0.7–4
D (SEM, nm) 6–20
Impurities total, % Al, % Co 3.16,
(Also reported 13 % for total impurities) 3.00 x 10-4, 2.39
Defects 1.12
MWCNTs/Helix Materials Solutions, Inc. (Richardson, TX) MWCNT [53–55]
L (TEM, μm) 0.3–50
D (TEM, nm) 10–30
Purity (TGA, %) >94
Metal content % Ni, %La (ICP-AES) 0.34 and 0.03
by weight
Metal %Ni (EDX) 0.12
SSA (BET, m2/g) 109
Zeta potential (mV) -13 ± 2
Characterization parameters such as length (L), diameter (D), specific surface area (SSA), density, trace metal content, and zeta potential are given for different
MWCNTs in addition to the techniques (where available) used for measuring each of the parameters. The techniques used include Brunauer, Emmett and Teller
(BET), scanning electron microscopy (SEM), transmission electron microscopy (TEM), inductively coupled plasma atomic emission spectroscopy (ICP-AES),
thermogravimetric analysis (TGA), atomic absorption spectroscopy (AAS), and energy-dispersive X-ray spectroscopy (EDX)
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the MWCNT. The published literature shows that NM
cytotoxicity, including MWCNTs, is proportionally re-
lated to the dose (or concentration) in terms of mass or
particle number, internalized within individual cells, and
averaged among the entire cell population. As internal-
ized dose increases, cytotoxicity also increases [61, 62].
Two instruments can be used to determine cellular
uptake: TEM is used as a qualitative assessment, while
inductively coupled plasma-mass spectroscopy (ICP-MS)
is used as a quantitative measure. In the case of
MWCNTs, the internalized dose can also be determined
directly by elemental carbon analysis or indirectly by
measuring the amount of trace metal impurities associ-
ated with the MWCNTs using ICP-MS based techniques
[63]. Ashing methods have also been developed for
measuring the trace metal content, which can then be
used to calculate the total dose [64, 65]. In addition to
providing some insight into the total dose delivered,
determination of trace metal content is an important
analytic output since low concentrations of metals may
impact the observed toxicological outcome or confound
other results [66].
Stage 5: NM transformations
The fifth stage of characterization is measured post-
exposure throughout the course of the assay. It is well
known that the physico-chemical properties of NMs
change when suspended in aqueous media. Particles can
undergo changes, such as agglomeration (both homoag-
glomeration (agglomeration with NMs) and heteroagglo-
meration (agglomeration with other matrix-specific
colloids)), dissolution, and oxidation, as well as changes
in surface properties (biodegradation and corona forma-
tion). Therefore, collecting aliquots of MWCNTs at dif-
ferent time points in the study is key in evaluating
particle transformations [67]. For example, samples
should be analyzed using TEM (to record changes in
size and/or agglomeration) and ICP-MS (to determine
loss of ionic function).
Thorough characterization can help to define parame-
ters specific to MWCNTs for in silico modeling. For
instance, the Multi-Path Particle Dosimetry (MPPD)
model (available from Applied Research Associates,
Inc.) and the In vitro Sedimentation, Diffusion, and
Dosimetry (ISDD) model have been used to estimate
deposited dose based on particle size for interspecies
extrapolation of particle exposures in various species
and to understand the kinetics of MWCNTs in the in
vitro systems [42, 68, 69]. Such models can be used
to make predictions regarding MWCNT fate and
transport in complex biological systems that can help
in designing in vitro systems that are more predictive
of in vivo conditions.
Conclusions
Simulating human-relevant exposure is critical for asses-
sing the toxicological potential of MWCNTs in in vitro
systems. When evaluating pulmonary effects (e.g., the
development of fibrosis) related to MWCNT exposure
for human risk assessment, exposure of relevant cell
types (representing the respiratory tract) to aerosolized
MWCNTs at the ALI holds greater physiological rele-
vance than traditional submerged cultures. Assessment
of inhalation toxicity using cells exposed at the ALI re-
quires an aerosol generator and an exposure chamber.
For MWCNTs, all exposure apparatus discussed in this
review met the critical needs to establish a robust
method, but none address all aspects of an ideal in vitro
exposure platform. For example, options not currently
included in any model include high throughput capabil-
ities (>10,000 samples per day), available real-time sam-
pling of the basolateral compartment, and generation of
fluid shear stress in the basolateral compartment.
The set-up and use of aerosol generation, exposure,
and characterization systems requires knowledge about
the engineering aspects of aerosol generation and
characterization, in addition to the biology of morpho-
logically distinct respiratory tract cells cultured at the
ALI. Because of the interdisciplinary nature of the topic,
this manuscript fills a critical need of putting forth the
parameters that are critical to consider while assessing
the inhalation toxicity of MWCNTs using in vitro
methods. These parameters include choice of aerosol
generation and exposure equipment to study the rele-
vant route and duration of exposure, context-specific
characterization of MWCNTs and their transformations
at various lifecycle stages, and evaluation of in vitro data
in the light of existing information. Although this manu-
script focuses on MWCNTs, the technical consider-
ations described here can be applied to the evaluation of
inhalation toxicity of other NMs and substances. Devel-
opment of research strategies based on the parameters
evaluated in this manuscript can help in generating
comprehensive information on biological endpoints rele-
vant to inhalation exposure to NMs or other larger res-
pirable aerosol particulates, which could be used in the
hazard ranking of substances in the risk assessment
process.
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